Source: Annual Congress 2005 - Assessment of lung function and side-effects in various diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Magula, J. Plutinsky, E. Ruttkayova, K. Bitter, S. Petricek (Nitra, Slovakia). Bone mineral density (BMD) measuring in patients suffering from pulmonary disease under glucocorticoid treatment - fashioned trend or necessity?. Eur Respir J 2005; 26: Suppl. 49, 3417

Member's Comments

No comment yet.

Related content which might interest you: Undertreatment of loss of bone mineral density in patients with COPD who were referred for pulmonary rehabilitation Source: Eur Respir J 2006; 28: Suppl. 50, 71s Year: 2006 Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021 Current status of research on osteoporosis in COPD: a systematic review Source: Eur Respir J 2009; 34: 209-218 Year: 2009 Bone mineral density changes in male patients with chronic obstructive pulmonary disease: clinical and biochemical variables in correlation with glucocorticoids use Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009 Bone mineral density (BMD) in male patients with chronic obstructive pulmonary disease (COPD) in age 40-70 years Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease Year: 2011 The likelihood of low bone mineral density (BMD) in male patients with chronic obstructive pulmonary disease (COPD) in age 40-70 years Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 Bone mineral density in patients with COPD depending on pulmonary function parameters Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Severe asthma and high doses of corticosteroid adversely impact trabecular bone score more than bone mineral density Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler(R) Source: Eur Respir J 2002; 19: 1058-1063 Year: 2002 Loss of bone mineral density in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Primary care management of COPD Year: 2007 Changes in bone mineral density of lumbar spine during one year in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 539s Year: 2001 Biomarkers to predict decreased bone mineral density in patients with chronic respiratory failure Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Peak bone mineral density (BMD) in children with asthma treated for a mean of 14 years with inhaled budesonide Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 A comparison of bone mineral density in elderly patients with COPD and bronchial asthma Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Clinical impact of the relationship between low bone mineral density and peripheral muscle strength in patients with COPD Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests Year: 2012 The relationships between sarcopenia and decreased bone mineral density in each obstructive airway disease phenotype of Korea. Source: International Congress 2017 – Clinical points to ponder in asthma Year: 2017 Determinants of bone mineral density in the lumbar spine instable patients with COPD Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Relationship between annual change of bone mineral density, emphysema and pulmonary function in patients with COPD Source: International Congress 2015 – COPD: notable points Year: 2015 Bone mineral density and calciun metabolism in sarcoidosis at clinical onset Source: Eur Respir J 2004; 24: Suppl. 48, 714s Year: 2004 Changes in bone mineral density and fat-free mass following pulmonary rehabilitation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 607s Year: 2006